Common chemotherapy drug can cause fatal reactionJune 9th, 2009 - 3:50 pm ICT by ANI
Washington, June 9 (ANI): A chemotherapy drug used to treat cancer is associated with fatal allergic reactions, say U.S. researchers.
Researchers at Northwestern University Feinberg School of Medicine identified 287 unique cases of hypersensitivity reactions submitted to the FDA’s Adverse Event Report System from 1997-2007, with 109 deaths in patients who received Cremophor-based paclitaxel, a solvent-administered taxane chemotherapy.
Adverse event reports generally only represent from 1 percent to 10 percent of actual incidence, so the number of hypersensitivity reactions and deaths is likely significantly higher, the researchers said.
Study leader Dr. Charles Bennett of Northwestern’s Feinberg School and Dennis Raisch of the University of New Mexico said the severe allergic reactions are believed to be caused by Cremophor, the chemical solvent — a derivative of castor oil — that is used to dissolve some insoluble drugs before they can be injected into the blood stream.
Two patients who died from an allergic reaction had early-stage breast cancer, which had been surgically removed, and were being treated with Cremophor-containing paclitaxel to prevent the cancer from coming back.
Both of those patients had received medications before the chemotherapy to reduce the risk of hypersensitivity reactions.
“The deaths of women with early-stage breast cancer are particularly disturbing because without the adverse reaction, they could have likely had 40 years of life ahead of them,” Bennett said.
The report was presented at the 45th annual meeting of the American Society of Clinical Oncology held in Orlando, Fla. (ANI)
- Breast cancer survivors are at higher risk for hip fractures - Feb 03, 2011
- New therapy shows promising result for HER2-positive metastatic disease - Oct 09, 2010
- Potential new target for treatment of ovarian cancer identified - Aug 17, 2010
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
- Circulating tumour cells in blood up death risk in early-stage breast cancer patients - Dec 11, 2010
- Urban kids more likely to develop food allergies - Jun 08, 2012
- Gene test may bring safe chemotherapy - Mar 23, 2012
- New chemical cocktail fences off breast cancer - Oct 07, 2009
- Alcohol intake after breast cancer diagnosis may increase recurrence risk - Sep 16, 2010
- Future docs may have to pass new breast exam test - Mar 25, 2011
- Gene set shows which patients benefit from chemo after surgery - Sep 08, 2010
- New discovery may help overcome taxane resistance in cancer - Jan 27, 2010
- Six mn US kids have food allergy: Study - Jun 21, 2011
- Breast cancer patients with diabetes '50pc more likely to die' - Jan 19, 2011
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
Tags: adverse event report system, adverse reaction, american society of clinical oncology, blood stream, breast cancer, castor oil, charles bennett, chemotherapy drug, dr charles, fatal allergic reactions, feinberg school of medicine, hypersensitivity reactions, northwestern university feinberg school of medicine, orlando fla, paclitaxel, raisch, school of medicine, stage breast cancer, study leader, university of new mexico